Biocerta Precision Diagnostics

Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision.'t fit the standard playbook, that's usually a sign of value that hasn't been captured yet.

Biocerta Precision Diagnostics
Biocerta Precision Diagnostics

/

Challenge

(01)

The Right Treatment Faster

Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision. Their CertaPath DST platform tests a patient's tumor against 200+ chemotherapy agents, giving oncologists clear, personalized data to select the right treatment faster and with greater confidence.

Biocerta Precision Diagnostics

Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision.'t fit the standard playbook, that's usually a sign of value that hasn't been captured yet.

Biocerta Precision Diagnostics
Biocerta Precision Diagnostics

/

Challenge

(01)

The Right Treatment Faster

The Right Treatment Faster

Biocerta Precision Diagnostics

Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision.'t fit the standard playbook, that's usually a sign of value that hasn't been captured yet.

Biocerta Precision Diagnostics

/

About the company

(01)

The Right Treatment Faster

Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision. Their CertaPath DST platform tests a patient's tumor against 200+ chemotherapy agents, giving oncologists clear, personalized data to select the right treatment faster and with greater confidence.